Women with polyendocrine metabolic ovarian syndrome more likely to have Alzheimer’s and dementia
Alzheimer’s disease and dementia may be more common in women with polyendocrine metabolic ovarian syndrome (PMOS), formerly known…
Sutter Health care model safely expands local Alzheimer’s treatment
A multidisciplinary care model developed across Sutter Health helped general neurologists address a practical challenge facing health systems…
Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says
Semaglutide—the diabetes and weight-loss drug known by brand names like Ozempic and Wegovy—is continuing to show its potential…
Popular Joint Supplement Tied to Faster Decline in Alzheimer’s Patients
Glucosamine, a widely used over-the-counter supplement for joint pain, may worsen outcomes in people with Alzheimer’s disease and…
Not All Exercise Protects Your Brain – One Type Is Linked to Higher Dementia Risk
Exercise may support brain health through changes in blood flow, metabolism, and inflammation, but those benefits do not…
High-Dose Vitamin D Linked to Better Cognition in Older Adults with Memory Problems and Poor Sleep
A small new study by Emory University scientists suggests that people with mild cognitive impairment and disturbed sleep…
Landmark map of human brain’s gene activity holds clues to Alzheimer’s disease and more
A detailed brain map describes gene activity in neurons (artist’s illustration) as well as immune and vascular cells…
Active form of meprin-β protein increases in people with Alzheimer’s disease
A team from the Altered Molecular Mechanism in Alzheimer’s Disease and Dementia laboratory, led by Javier Sáez Valero,…
The drugs that could slow Alzheimer’s
New treatments for Alzheimer’s that significantly slow down its progression could become available through the NHS in the…
New dementia drugs could become available on the NHS
Health Secretary Yvette Cooper has raised hopes that a breakthrough dementia drug could be made available on the…
Dementia drugs made in UK but denied on NHS
But there is a danger in allowing dementia policy to become only a conversation about care. A country…
APOE genotype helps p-tau217 predict who may develop cognitive impairment sooner
A pooled analysis across seven multiethnic cohorts examines whether the same p-tau217 reading carries the same prognostic meaning…